Hong et al. revealed that exosomes generated from bone marrow-derived MSCs could convey siRNA-GRP78 to recipient liver cancer cells and inhibit the expression of GRP78 so as to enhance the sensitivity of cancer cells to sorafenib (Li H. et al., 2018). This evidence concerns the gene HSPA5 and cancer.